A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase - Concepedia

Concepedia

Publication | Open Access

A new series of neutral 5-substituted 4-anilinoquinazolines as potent, orally active inhibitors of erbB2 receptor tyrosine kinase

DOI Full Paper Access

18

Citations

9

References

2007

Year

Bernard Barlaam, Peter Ballard, Robert H. Bradbury, Richard Ducray, Hervé Germain, D. Mark Hickinson, Kevin Hudson, Jason G. Kettle, Teresa Klinowska, Françoise Magnien,

Bioorganic & Medicinal Chemistry Letters

Medicinal ChemistryNeutral 5-Substituted 4-AnilinoquinazolinesBiochemistryMedicineActive InhibitorsNatural SciencesRational Drug DesignMechanism Of ActionPharmacological AgentPharmacotherapyNew SeriesDrug DevelopmentPharmacologyDrug Discovery

References

	Year	Citations

Page 1

Page 1